Research Article

You have full text access to this OnlineOpen article

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

  1. K. N. Verpoort*,
  2. C. M. Jol-van der Zijde,
  3. E. A. M. Papendrecht-van der Voort,
  4. A. Ioan-Facsinay,
  5. J. W. Drijfhout,
  6. M. J. D. van Tol,
  7. F. C. Breedveld,
  8. T. W. J. Huizinga,
  9. R. E. M. Toes

Article first published online: 28 NOV 2006

DOI: 10.1002/art.22279

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 12, pages 3799–3808, December 2006

Additional Information

How to Cite

Verpoort, K. N., Jol-van der Zijde, C. M., Papendrecht-van der Voort, E. A. M., Ioan-Facsinay, A., Drijfhout, J. W., van Tol, M. J. D., Breedveld, F. C., Huizinga, T. W. J. and Toes, R. E. M. (2006), Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis & Rheumatism, 54: 3799–3808. doi: 10.1002/art.22279

Author Information

  1. Leiden University Medical Center, Leiden, The Netherlands

*Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands

Publication History

  1. Issue published online: 28 NOV 2006
  2. Article first published online: 28 NOV 2006
  3. Manuscript Accepted: 11 SEP 2006
  4. Manuscript Received: 19 MAY 2006

Funded by

  • Dutch Arthritis Association
  • Gratama Foundation
  • Leiden University Fund
  • Autocure European Consortium
  • Vidi grant from The Netherlands Organization for Scientific Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

REFERENCES

  • 1
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63.
    Direct Link:
  • 2
    Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50: 709–15.
    Direct Link:
  • 3
    Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62: 120–6.
  • 4
    Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961–73.
  • 5
    Brinkman DM, Jol-van der Zijde CM, ten Dam MM, Vossen JM, Osterhaus AD, Kroon FP, et al. Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. J Clin Immunol 2003; 23: 528–38.
  • 6
    Saxon A, Stiehm ER. The B-lymphocyte system. In: StiehmER, editor. Immunologic disorders in infants and children. Philadelphia: W. B. Saunders; 1989. p. 50.
  • 7
    Ochsenbein AF, Pinschewer DD, Odermatt B, Ciurea A, Hengartner H, Zinkernagel RM. Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design. J Immunol 2000; 164: 6296–302.
  • 8
    Nimmerjahn F, Ravetch JV. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 2005; 310: 1510–2.
  • 9
    Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002; 2: 580–92.
  • 10
    Van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003; 21 Suppl 31: S100–5.
  • 11
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 12
    Jefferis R, Reimer CB, Skvaril F, de Lange GG, Goodall DM, Bentley TL, et al. Evaluation of monoclonal antibodies having specificity for human IgG subclasses: results of the 2nd IUIS/WHO collaborative study. Immunol Lett 1992; 31: 143–68.
  • 13
    Jefferis R, Reimer CB, Skvaril F, de Lange G, Ling NR, Lowe J, et al. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett 1985; 10: 223–52.
  • 14
    Aalberse RC, van der Graag R, van Leeuwen J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 1983; 130: 722–6.
  • 15
    Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004; 50: 3485–94.
    Direct Link:
  • 16
    Helfand RF, Gary HE Jr, Atkinson WL, Nordin JD, Keyserling HL, Bellini WJ. Decline of measles-specific immunoglobulin M antibodies after primary measles, mumps, and rubella vaccination. Clin Diagn Lab Immunol 1998; 5: 135–8.
  • 17
    Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54: 1117–21.
    Direct Link:
  • 18
    Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380–6.
    Direct Link:
  • 19
    Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741–9.
    Direct Link:
  • 20
    Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol 2005; 139: 542–50.
    Direct Link:
  • 21
    Lucas AH. IgG subclass-restricted immune responses to allergens. Springer Semin Immunopathol 1990; 12: 385–400.
  • 22
    Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 2005; 54 Suppl 2: S52–61.
  • 23
    Seissler J, Eikamp K, Schott M, Scherbaum WA. IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes. Horm Metab Res 2002; 34: 186–91.
  • 24
    Hoppu S, Harkonen T, Ronkainen MS, Simell S, Hekkala A, Toivonen A, et al. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes. Clin Exp Immunol 2006; 144: 59–66.
    Direct Link:
View Full Article (HTML) Get PDF (110K)